|
US2680749A
(en)
|
1951-12-01 |
1954-06-08 |
Eastman Kodak Co |
Water-soluble tocopherol derivatives
|
|
US2742487A
(en)
|
1952-05-02 |
1956-04-17 |
Coconut Processes Inc |
Method of extracting oil from mature, fresh coconut meats
|
|
US3097139A
(en)
|
1960-03-10 |
1963-07-09 |
Ici Ltd |
Hypocholesterolaemia compositions
|
|
US3097144A
(en)
|
1960-10-14 |
1963-07-09 |
Upjohn Co |
Heat-cured, polymeric, medicinal dosage film coatings containing a polyvinylpyrrolidone copolymer, polyethenoid acid, and polyethylene glycol
|
|
CH399447A
(de)
|
1961-04-14 |
1965-09-30 |
Ciba Geigy |
Verfahren zur Herstellung eines neuen Steroid-Hormon-Esters
|
|
US3164520A
(en)
|
1962-10-29 |
1965-01-05 |
Olin Mathieson |
Injectable steroid compositions containing at least 75% benzyl benzoate
|
|
US3510561A
(en)
|
1965-05-20 |
1970-05-05 |
Canada Packers Ltd |
Sulfone-enhanced heparin absorption through mucous membranes
|
|
FR1578974A
(OSRAM)
|
1968-05-16 |
1969-08-22 |
|
|
|
NL189235C
(nl)
|
1974-02-28 |
1993-02-16 |
Akzo Nv |
Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.
|
|
US4147783A
(en)
|
1974-02-28 |
1979-04-03 |
Akzona Incorporated |
Oral pharmaceutical preparation
|
|
US4098802A
(en)
|
1975-02-18 |
1978-07-04 |
Akzona Incorporated |
Oral pharmaceutical preparation having androgenic activity
|
|
JPS5266616A
(en)
|
1975-11-29 |
1977-06-02 |
Sawai Seiyaku Kk |
Manufacturing of solidified oily liquid substance
|
|
GB1567515A
(en)
|
1976-05-28 |
1980-05-14 |
Akzo Nv |
Esters of testo-sterone and 5 -dihydro-testosterone
|
|
FR2374910A1
(fr)
|
1976-10-23 |
1978-07-21 |
Choay Sa |
Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations
|
|
FR2408345A1
(fr)
|
1976-11-30 |
1979-06-08 |
Besins Jean Louis |
Nouvelle composition a action anti-conceptionnelle
|
|
DK25877A
(da)
|
1977-01-21 |
1978-08-15 |
Nordisk Insulinlab |
Fremgangsmaade til udvinding af renset albumin fra blodplasma
|
|
JPS53107408A
(en)
|
1977-02-28 |
1978-09-19 |
Yamanouchi Pharmaceut Co Ltd |
Micellar preparation for rectal infusion
|
|
FI65914C
(fi)
|
1978-03-07 |
1984-08-10 |
Sandoz Ag |
Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
|
|
NZ196349A
(en)
|
1980-03-07 |
1984-08-24 |
Interx Research Corp |
Enhancement of absorption rate of orally administered polar bioactive agents
|
|
JPS5770824A
(en)
|
1980-10-20 |
1982-05-01 |
Nippon Saafuakutanto Kogyo Kk |
Vehicle for medicine
|
|
FR2494112B1
(OSRAM)
|
1980-11-19 |
1986-01-10 |
Laruelle Claude |
|
|
FR2502951B1
(fr)
|
1981-04-06 |
1985-12-06 |
Sandoz Sa |
Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
|
|
US4439432A
(en)
|
1982-03-22 |
1984-03-27 |
Peat Raymond F |
Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
|
|
US4654327A
(en)
|
1982-04-21 |
1987-03-31 |
Research Corp. |
Quaternary ammonium complexes of heparin
|
|
DE3237814A1
(de)
|
1982-10-12 |
1984-04-12 |
Warner-Lambert Co., 07950 Morris Plains, N.J. |
Wasserfreie emulsionen und verwendung derselben
|
|
SE8206744D0
(sv)
|
1982-11-26 |
1982-11-26 |
Fluidcarbon International Ab |
Preparat for kontrollerad avgivning av substanser
|
|
IL68769A
(en)
|
1983-05-23 |
1986-02-28 |
Hadassah Med Org |
Pharmaceutical compositions containing insulin for oral administration
|
|
US4731384A
(en)
|
1983-07-01 |
1988-03-15 |
Troponwerke Gmbh & Co, Kg |
Etofenamate formulation
|
|
US4832952A
(en)
|
1983-07-07 |
1989-05-23 |
American Home Products Corporation |
Pharmaceutical composition containing a liquid lubricant
|
|
DE3331009A1
(de)
|
1983-08-27 |
1985-03-14 |
Basf Ag, 6700 Ludwigshafen |
Verfahren zur erhoehung der enteralen resorbierbarkeit von heparin bzw. heparinoiden sowie das so erhaeltliche heparin- bzw. heparinoidpraeparat
|
|
DE3406497A1
(de)
|
1984-02-23 |
1985-09-05 |
Mueller Bernhard Willi Werner |
Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
|
|
US4713246A
(en)
|
1984-03-19 |
1987-12-15 |
Bristol-Myers Company |
Etoposide oral dosage form
|
|
US4795327A
(en)
|
1984-03-26 |
1989-01-03 |
Forest Laboratories, Inc. |
Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
|
|
US4572915A
(en)
|
1984-05-01 |
1986-02-25 |
Bioglan Laboratories |
Clear micellized solutions of fat soluble essential nutrients
|
|
US4703042A
(en)
|
1984-05-21 |
1987-10-27 |
Bodor Nicholas S |
Orally active heparin salts containing multivalent cationic units
|
|
GB8414221D0
(en)
|
1984-06-04 |
1984-07-11 |
Sterwin Ag |
Unit dosage form
|
|
DE3421468A1
(de)
|
1984-06-08 |
1985-12-19 |
Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim |
Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
|
|
GB8903804D0
(en)
|
1989-02-20 |
1989-04-05 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
|
US5639724A
(en)
|
1984-07-24 |
1997-06-17 |
Sandoz Ltd. |
Cyclosporin galenic forms
|
|
JPS6150978A
(ja)
|
1984-08-16 |
1986-03-13 |
Takeda Chem Ind Ltd |
ピリジン誘導体およびその製造法
|
|
US4897269A
(en)
|
1984-09-24 |
1990-01-30 |
Mezei Associates Limited |
Administration of drugs with multiphase liposomal delivery system
|
|
US4867984A
(en)
|
1984-11-06 |
1989-09-19 |
Nagin K. Patel |
Drug in bead form and process for preparing same
|
|
CA1282326C
(en)
|
1984-12-14 |
1991-04-02 |
Paul J. Jarosz |
Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
|
|
DE3500103C2
(de)
|
1985-01-04 |
1987-01-22 |
R.P. Scherer GmbH, 6930 Eberbach |
Pharmazeutische Zubereitung mit einem in Wasser und Verdauungssäften schwer löslichen Wirkstoff
|
|
US4874795A
(en)
|
1985-04-02 |
1989-10-17 |
Yesair David W |
Composition for delivery of orally administered drugs and other substances
|
|
US4628052A
(en)
|
1985-05-28 |
1986-12-09 |
Peat Raymond F |
Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities
|
|
FR2585246A1
(fr)
|
1985-07-26 |
1987-01-30 |
Cortial |
Procede d'obtention de formes pharmaceutiques solides a liberation prolongee
|
|
US4717596A
(en)
|
1985-10-30 |
1988-01-05 |
International Business Machines Corporation |
Method for vacuum vapor deposition with improved mass flow control
|
|
US5023108A
(en)
|
1986-01-13 |
1991-06-11 |
Research Corporation |
Aqueous dispersions of waxes and lipids for pharmaceutical coating
|
|
CA1327010C
(en)
|
1986-02-13 |
1994-02-15 |
Tadashi Makino |
Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
|
|
US5433959A
(en)
|
1986-02-13 |
1995-07-18 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
|
US4849227A
(en)
|
1986-03-21 |
1989-07-18 |
Eurasiam Laboratories, Inc. |
Pharmaceutical compositions
|
|
US4963540A
(en)
|
1986-04-16 |
1990-10-16 |
Maxson Wayne S |
Method for treatment of premenstrual syndrome
|
|
US5140021A
(en)
|
1986-04-16 |
1992-08-18 |
Genesis Systems Corporation |
Method and dosage form for treatment of premenstrual syndrome
|
|
SE457693B
(sv)
|
1986-07-01 |
1989-01-23 |
Drilletten Ab |
Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
|
|
FR2602423B1
(fr)
|
1986-08-08 |
1989-05-05 |
Ethypharm Sa |
Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
|
|
EP0318492A1
(en)
|
1986-08-11 |
1989-06-07 |
Innovata Biomed Limited |
Pharmaceutical formulations comprising microcapsules
|
|
US5071643A
(en)
|
1986-10-17 |
1991-12-10 |
R. P. Scherer Corporation |
Solvent system enhancing the solubility of pharmaceuticals for encapsulation
|
|
GB8630273D0
(en)
|
1986-12-18 |
1987-01-28 |
Til Medical Ltd |
Pharmaceutical delivery systems
|
|
NL194638C
(nl)
|
1986-12-19 |
2002-10-04 |
Novartis Ag |
Hydrosol die vaste deeltjes van een farmaceutisch actieve stof bevat en farmaceutisch preparaat dat deze hydrosol bevat.
|
|
JPH0662402B2
(ja)
|
1987-01-14 |
1994-08-17 |
アライアンス ファーマシューチカル コーポレイション |
臭素化ペルフルオロカーボンエマルジョン及びその製造方法
|
|
US5026560A
(en)
|
1987-01-29 |
1991-06-25 |
Takeda Chemical Industries, Ltd. |
Spherical granules having core and their production
|
|
US4900734A
(en)
|
1987-08-27 |
1990-02-13 |
Maxson Wayne S |
Novel pharmaceutical composition containing estradiol and progesterone for oral administration
|
|
US5756450A
(en)
|
1987-09-15 |
1998-05-26 |
Novartis Corporation |
Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
|
|
US5035891A
(en)
|
1987-10-05 |
1991-07-30 |
Syntex (U.S.A.) Inc. |
Controlled release subcutaneous implant
|
|
US5244925A
(en)
|
1987-12-18 |
1993-09-14 |
Kabi Pharmacia Aktiebolag |
Emulsion for parenteral administration
|
|
GB8730011D0
(en)
|
1987-12-23 |
1988-02-03 |
Smithkline Dauelsberg |
Pharmaceutical compositions
|
|
FR2627696B1
(fr)
|
1988-02-26 |
1991-09-13 |
Fournier Innovation Synergie |
Nouvelle forme galenique du fenofibrate
|
|
DE3807895A1
(de)
|
1988-03-10 |
1989-09-21 |
Knoll Ag |
Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker
|
|
US5350741A
(en)
|
1988-07-30 |
1994-09-27 |
Kanji Takada |
Enteric formulations of physiologically active peptides and proteins
|
|
US5342625A
(en)
|
1988-09-16 |
1994-08-30 |
Sandoz Ltd. |
Pharmaceutical compositions comprising cyclosporins
|
|
KR0148748B1
(ko)
|
1988-09-16 |
1998-08-17 |
장 크라메르, 한스 루돌프 하우스 |
사이클로스포린을 함유하는 약학조성물
|
|
US6007840A
(en)
|
1988-09-16 |
1999-12-28 |
Novartis Ag |
Pharmaceutical compositions comprising cyclosporins
|
|
GB8822857D0
(en)
|
1988-09-29 |
1988-11-02 |
Patralan Ltd |
Pharmaceutical formulations
|
|
DE3838094A1
(de)
|
1988-11-10 |
1990-05-17 |
Nordmark Arzneimittel Gmbh |
Feste pharmazeutische retardform
|
|
US4994439A
(en)
|
1989-01-19 |
1991-02-19 |
California Biotechnology Inc. |
Transmembrane formulations for drug administration
|
|
US5364632A
(en)
|
1989-04-05 |
1994-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Medicinal emulsions
|
|
FR2647346B1
(fr)
|
1989-05-29 |
1991-09-06 |
Besins Iscovesco Laboratoires |
Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicament
|
|
US5104656A
(en)
|
1989-06-16 |
1992-04-14 |
Seth Pyare L |
Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent
|
|
DE3919982A1
(de)
|
1989-06-19 |
1990-12-20 |
Liedtke Pharmed Gmbh |
Orale lipidarzneiform
|
|
US5532002A
(en)
|
1989-08-17 |
1996-07-02 |
Cortecs Limited |
Gelatin pharmaceutical formulations
|
|
US5091188A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
US5091187A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
US5298497A
(en)
|
1990-05-15 |
1994-03-29 |
E. R. Squibb & Sons, Inc. |
Method for preventing onset of hypertension employing a cholesterol lowering drug
|
|
ATE121618T1
(de)
|
1990-08-13 |
1995-05-15 |
David W Yesair |
Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien.
|
|
US5270005A
(en)
|
1990-09-07 |
1993-12-14 |
Baxter International Inc. |
Extracorporeal blood oxygenation system incorporating integrated reservoir-membrane oxygenerator-heat exchanger and pump assembly
|
|
US5665379A
(en)
|
1990-09-28 |
1997-09-09 |
Pharmacia & Upjohn Aktiebolag |
Lipid particle forming matrix, preparation and use thereof
|
|
DE69124459T3
(de)
|
1990-11-02 |
2001-05-31 |
Novartis Ag, Basel |
Zyklosporine
|
|
US5152997A
(en)
|
1990-12-11 |
1992-10-06 |
Theratech, Inc. |
Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
IT1245761B
(it)
|
1991-01-30 |
1994-10-14 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
|
|
US5300529A
(en)
|
1991-02-12 |
1994-04-05 |
Isp Investments Inc. |
Stable, clear, efficacious aqueous microemulsion compositions containing a high loading of a water-insoluble, agriculturally active chemical
|
|
US5403593A
(en)
|
1991-03-04 |
1995-04-04 |
Sandoz Ltd. |
Melt granulated compositions for preparing sustained release dosage forms
|
|
TW212139B
(OSRAM)
|
1991-04-15 |
1993-09-01 |
Yamanouchi Pharma Co Ltd |
|
|
DE69229779T2
(de)
|
1991-04-19 |
1999-12-23 |
Lds Technologies, Inc. |
Konvertierbare mikroemulsionsverbindungen
|
|
US5688761A
(en)
|
1991-04-19 |
1997-11-18 |
Lds Technologies, Inc. |
Convertible microemulsion formulations
|
|
US5223268A
(en)
|
1991-05-16 |
1993-06-29 |
Sterling Drug, Inc. |
Low solubility drug-coated bead compositions
|
|
US5380535A
(en)
|
1991-05-28 |
1995-01-10 |
Geyer; Robert P. |
Chewable drug-delivery compositions and methods for preparing the same
|
|
US5698155A
(en)
|
1991-05-31 |
1997-12-16 |
Gs Technologies, Inc. |
Method for the manufacture of pharmaceutical cellulose capsules
|
|
DK0597007T3
(da)
|
1991-07-26 |
1996-11-18 |
Smithkline Beecham Corp |
V/O mikroemulsioner
|
|
WO1993006921A1
(en)
|
1991-10-04 |
1993-04-15 |
Gs Biochem Ab |
Particles, method of preparing said particles and uses thereof
|
|
JPH0597672A
(ja)
|
1991-10-08 |
1993-04-20 |
Terumo Corp |
アミド誘導体含有固形製剤およびその製造方法
|
|
CZ282760B6
(cs)
|
1991-11-22 |
1997-09-17 |
Procter And Gamble Pharmaceuticals, Inc. |
Risedronátové prostředky se zpožděným uvolňováním
|
|
US5206219A
(en)
|
1991-11-25 |
1993-04-27 |
Applied Analytical Industries, Inc. |
Oral compositions of proteinaceous medicaments
|
|
HUT63579A
(en)
|
1991-12-20 |
1993-09-28 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
|
|
JP3852621B2
(ja)
|
1992-01-21 |
2006-12-06 |
あすか製薬株式会社 |
血管内皮細胞機能改善剤
|
|
GB9201857D0
(en)
|
1992-01-29 |
1992-03-18 |
Smithkline Beecham Plc |
Novel compound
|
|
US5571533A
(en)
|
1992-02-07 |
1996-11-05 |
Recordati, S.A., Chemical And Pharmaceutical Company |
Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
|
|
SE9200951D0
(sv)
|
1992-03-27 |
1992-03-27 |
Kabi Pharmacia Ab |
Pharmaceutical composition containing a defined lipid system
|
|
GB9212511D0
(en)
|
1992-06-12 |
1992-07-22 |
Cortecs Ltd |
Pharmaceutical compositions
|
|
IT1255449B
(it)
|
1992-06-30 |
1995-10-31 |
Fabio Berlati |
Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
|
|
PH30929A
(en)
|
1992-09-03 |
1997-12-23 |
Janssen Pharmaceutica Nv |
Beads having a core coated with an antifungal and a polymer.
|
|
JPH08505367A
(ja)
|
1992-10-16 |
1996-06-11 |
スミスクライン・ビーチャム・コーポレイション |
医薬用エマルジョン組成物
|
|
US5376688A
(en)
|
1992-12-18 |
1994-12-27 |
R. P. Scherer Corporation |
Enhanced solubility pharmaceutical solutions
|
|
GB9300875D0
(en)
|
1993-01-18 |
1993-03-10 |
Ucb Sa |
Nanocapsule containing pharmaceutical compositions
|
|
US5686105A
(en)
|
1993-10-19 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
|
DE4312034A1
(de)
|
1993-04-13 |
1994-10-20 |
Hesch Rolf Dieter Prof Dr Med |
Neuartige Androgene und Anabolika
|
|
ATE223231T1
(de)
|
1993-04-19 |
2002-09-15 |
Inst Advanced Skin Res Inc |
Mikroemulsionszubereitung enthaltend eine schwer absorbierbare substanz
|
|
BE1006990A5
(nl)
|
1993-04-22 |
1995-02-07 |
Univ Gent |
Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
|
|
PT621032E
(pt)
|
1993-04-23 |
2001-01-31 |
Novartis Ag |
Dispositivo de distribuicao de libertacao controlada de farmaco
|
|
NZ247516A
(en)
|
1993-04-28 |
1995-02-24 |
Bernard Charles Sherman |
Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
|
|
SE9302135D0
(sv)
|
1993-06-18 |
1993-06-18 |
Kabi Pharmacia Ab |
New pharmaceutical composition
|
|
US5639474A
(en)
|
1993-07-01 |
1997-06-17 |
Hanmi Pharm. Ind., Ltd. |
Cyclosporin soft capsule composition
|
|
DE4322826A1
(de)
|
1993-07-08 |
1995-01-12 |
Galenik Labor Freiburg Gmbh |
Pharmazeutisches Präparat
|
|
ES2068762B1
(es)
|
1993-07-21 |
1995-12-01 |
Lipotec Sa |
Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
|
|
JPH0741422A
(ja)
|
1993-07-30 |
1995-02-10 |
Nissui Pharm Co Ltd |
γ−オリザノールの水への可溶化方法
|
|
TW359614B
(en)
|
1993-08-31 |
1999-06-01 |
Takeda Chemical Industries Ltd |
Composition containing benzimidazole compounds for rectal administration
|
|
ES2145102T3
(es)
|
1993-09-09 |
2000-07-01 |
Takeda Chemical Industries Ltd |
Formulacion que comprende una sustancia antibacteriana y una sustancia antiulcerosa.
|
|
US6022852A
(en)
|
1993-10-22 |
2000-02-08 |
Hexal Ag |
Pharmaceutical composition containing cyclosporin A
|
|
AU692506B2
(en)
|
1993-11-17 |
1998-06-11 |
Ibah, Inc. |
Transparent liquid for encapsulated drug delivery
|
|
DE4340781C3
(de)
|
1993-11-30 |
2000-01-27 |
Novartis Ag |
Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
|
|
US5374446A
(en)
|
1993-12-10 |
1994-12-20 |
Arco Chemical Technology, L.P. |
Linked esterified alkoxylated polyols useful as reduced calorie fat substitutes
|
|
KR0146671B1
(ko)
|
1994-02-25 |
1998-08-17 |
김충환 |
사이클로스포린-함유 분말 조성물
|
|
US5811120A
(en)
|
1994-03-02 |
1998-09-22 |
Eli Lilly And Company |
Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
|
|
GB9405304D0
(en)
|
1994-03-16 |
1994-04-27 |
Scherer Ltd R P |
Delivery systems for hydrophobic drugs
|
|
US5731356A
(en)
|
1994-03-22 |
1998-03-24 |
Zeneca Limited |
Pharmaceutical compositions of propofol and edetate
|
|
GB9409778D0
(en)
|
1994-05-16 |
1994-07-06 |
Dumex Ltd As |
Compositions
|
|
SE518578C2
(sv)
|
1994-06-15 |
2002-10-29 |
Gs Dev Ab |
Lipidbaserad komposition
|
|
US6692766B1
(en)
|
1994-06-15 |
2004-02-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Controlled release oral drug delivery system
|
|
US5817320A
(en)
|
1994-06-20 |
1998-10-06 |
The United States Of America As Represented By The Secretary Of The Agriculture |
In ovo immunization of avian embryos with oil-emulsion vaccines
|
|
US5616330A
(en)
|
1994-07-19 |
1997-04-01 |
Hemagen/Pfc |
Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
|
|
FR2722984B1
(fr)
|
1994-07-26 |
1996-10-18 |
Effik Lab |
Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
|
|
GB9417524D0
(en)
|
1994-08-31 |
1994-10-19 |
Cortecs Ltd |
Pharmaceutical compositions
|
|
SE518619C2
(sv)
|
1994-12-09 |
2002-10-29 |
Gs Dev Ab |
Komposition för reglerad frisättning innehållande monokaproin
|
|
US5858398A
(en)
|
1994-11-03 |
1999-01-12 |
Isomed Inc. |
Microparticular pharmaceutical compositions
|
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
|
KR0167613B1
(ko)
|
1994-12-28 |
1999-01-15 |
한스 루돌프 하우스, 니콜 케르커 |
사이클로스포린-함유 연질캅셀제 조성물
|
|
US5545628A
(en)
|
1995-01-10 |
1996-08-13 |
Galephar P.R. Inc. |
Pharmaceutical composition containing fenofibrate
|
|
US5629021A
(en)
|
1995-01-31 |
1997-05-13 |
Novavax, Inc. |
Micellar nanoparticles
|
|
FR2730231B1
(fr)
|
1995-02-02 |
1997-04-04 |
Fournier Sca Lab |
Association de fenofibrate et de vitamine e, utilisation en therapeutique
|
|
US5560931A
(en)
|
1995-02-14 |
1996-10-01 |
Nawosystems L.L.C. |
Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
|
|
US5571536A
(en)
|
1995-02-06 |
1996-11-05 |
Nano Systems L.L.C. |
Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
|
|
US5573783A
(en)
|
1995-02-13 |
1996-11-12 |
Nano Systems L.L.C. |
Redispersible nanoparticulate film matrices with protective overcoats
|
|
JP2740153B2
(ja)
|
1995-03-07 |
1998-04-15 |
エフ・ホフマン−ラ ロシユ アーゲー |
混合ミセル
|
|
US5653987A
(en)
|
1995-05-16 |
1997-08-05 |
Modi; Pankaj |
Liquid formulations for proteinic pharmaceuticals
|
|
SI9500173B
(sl)
|
1995-05-19 |
2002-02-28 |
Lek, |
Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
|
|
US5726181A
(en)
|
1995-06-05 |
1998-03-10 |
Bionumerik Pharmaceuticals, Inc. |
Formulations and compositions of poorly water soluble camptothecin derivatives
|
|
FR2737121B1
(fr)
|
1995-07-27 |
1997-10-03 |
Cl Pharma |
Nouvelles formulations galeniques du fenofibrate et leurs applications
|
|
US5766629A
(en)
|
1995-08-25 |
1998-06-16 |
Sangstat Medical Corporation |
Oral cyclosporin formulations
|
|
WO1998056357A1
(en)
|
1995-12-19 |
1998-12-17 |
Abbott Laboratories |
A controlled release formulation for poorly soluble basic drugs
|
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
|
JPH09241152A
(ja)
|
1996-03-01 |
1997-09-16 |
Sunstar Inc |
水中油型エマルション
|
|
IL117773A
(en)
|
1996-04-02 |
2000-10-31 |
Pharmos Ltd |
Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
|
|
GB9608719D0
(en)
|
1996-04-26 |
1996-07-03 |
Scherer Ltd R P |
Pharmaceutical compositions
|
|
DE19619045C1
(de)
|
1996-05-02 |
1997-11-13 |
Jenapharm Gmbh |
Verwendung von Kombinationspräparaten zur Behandlung hypogonadaler Männer sowie Männern mit Hypophysenerkrankungen
|
|
US6057339A
(en)
|
1996-05-09 |
2000-05-02 |
Bristol-Myers Squibb Company |
Method of inhibiting or treating phytosterolemia with an MTP inhibitor
|
|
WO1997048382A2
(en)
|
1996-06-18 |
1997-12-24 |
Otsuka Pharmaceutical Co., Ltd. |
Multiple-unit type prolonged action drug preparation
|
|
US5846971A
(en)
|
1996-06-28 |
1998-12-08 |
Schering Corporation |
Oral antifungal composition
|
|
CN1228693A
(zh)
|
1996-06-28 |
1999-09-15 |
先灵公司 |
含有三唑类抗真菌化合物的口服组合物
|
|
US5883109A
(en)
|
1996-07-24 |
1999-03-16 |
Bristol-Myers Squibb Company |
Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
|
|
NZ333657A
(en)
|
1996-07-30 |
2000-05-26 |
Novartis Ag |
A pharmaceutical composition comprising cyclosporin A and 40-O-(2-hydroxyethyl)-rapamycin
|
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
|
JP2000516244A
(ja)
|
1996-08-22 |
2000-12-05 |
リサーチ・トライアングル・ファーマシューティカルズ |
水不溶性物質の微粒子を含む組成物およびその製造方法
|
|
SE9603077D0
(sv)
|
1996-08-29 |
1996-08-29 |
Tetra Laval Holdings & Finance |
An apparatus for and a method of performing an animal-related action regarding at least a part of the body of an animal
|
|
US5891469A
(en)
|
1997-04-02 |
1999-04-06 |
Pharmos Corporation |
Solid Coprecipitates for enhanced bioavailability of lipophilic substances
|
|
US5798333A
(en)
|
1996-09-17 |
1998-08-25 |
Sherman; Bernard C. |
Water-soluble concentrates containing cyclosporins
|
|
US6361796B1
(en)
|
1996-10-25 |
2002-03-26 |
Shire Laboratories, Inc. |
Soluble form osmotic dose delivery system
|
|
WO1998029098A1
(en)
|
1996-12-31 |
1998-07-09 |
Inhale Therapeutic Systems, Inc. |
Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
|
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
FR2758459B1
(fr)
|
1997-01-17 |
1999-05-07 |
Pharma Pass |
Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
|
|
GB9700878D0
(en)
|
1997-01-17 |
1997-03-05 |
Scherer Ltd R P |
Dosage forms and method for ameliorating male erectile dysfunction
|
|
US6066653A
(en)
|
1997-01-17 |
2000-05-23 |
Bristol-Myers Squibb Co. |
Method of treating acid lipase deficiency diseases with an MTP inhibitor and cholesterol lowering drugs
|
|
ATE275963T1
(de)
|
1997-01-30 |
2004-10-15 |
Novartis Pharma Gmbh |
Ölfreie pharmazeutische zusammensetzung welche cyclosporin enthält
|
|
NZ510991A
(en)
|
1997-03-05 |
2002-11-26 |
Sugen Inc |
Use of formulations for hydrophobic pharmaceutical agents in treatment or prevention of cell proliferative disorders
|
|
CA2284000C
(en)
|
1997-03-12 |
2012-01-03 |
Abbott Laboratories |
Hydrophilic binary systems for the administration of cyclosporine
|
|
JPH1149664A
(ja)
|
1997-04-18 |
1999-02-23 |
Taisho Pharmaceut Co Ltd |
マイクロエマルション
|
|
EP0988858A1
(en)
|
1997-04-18 |
2000-03-29 |
Taisho Pharmaceutical Co., Ltd |
Microemulsion
|
|
US5874418A
(en)
|
1997-05-05 |
1999-02-23 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
|
|
US6046177A
(en)
|
1997-05-05 |
2000-04-04 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
|
US5981586A
(en)
|
1997-05-23 |
1999-11-09 |
Pershadsingh; Harrihar A. |
Methods for treating proliferative and inflammatory skin diseases
|
|
TW580397B
(en)
|
1997-05-27 |
2004-03-21 |
Takeda Chemical Industries Ltd |
Solid preparation
|
|
TR199903271T2
(en)
|
1997-06-27 |
2000-08-21 |
Astra Aktiebolag |
Tokoferol ile karl�la�t�r�lan soluma i�in prolipozom tozlar�.
|
|
ES2174462T3
(es)
|
1997-07-29 |
2002-11-01 |
Upjohn Co |
Formulacion autoestimulante para compuestos lipofilos.
|
|
IT1294760B1
(it)
|
1997-09-03 |
1999-04-12 |
Jagotec Ag |
Procedimento per la preparazione di compresse farmaceutiche in grado di cedere,secondo schemi predeterminabili, principi attivi poco
|
|
KR100222918B1
(ko)
|
1997-09-04 |
1999-10-01 |
윤덕용 |
γ-알루미나에 알칼리염 및 산화구리가 담지되어 있는 흡수제
|
|
CA2214895C
(en)
|
1997-09-19 |
1999-04-20 |
Bernard Charles Sherman |
Improved pharmaceutical composition comprising fenofibrate
|
|
US6296876B1
(en)
|
1997-10-06 |
2001-10-02 |
Isa Odidi |
Pharmaceutical formulations for acid labile substances
|
|
US20050070516A1
(en)
|
1997-10-28 |
2005-03-31 |
Vivus Inc. |
As-needed administration of an androgenic agent to enhance female desire and responsiveness
|
|
US20020013304A1
(en)
|
1997-10-28 |
2002-01-31 |
Wilson Leland F. |
As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness
|
|
US6027747A
(en)
|
1997-11-11 |
2000-02-22 |
Terracol; Didier |
Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
|
|
US5891845A
(en)
|
1997-11-21 |
1999-04-06 |
Fuisz Technologies Ltd. |
Drug delivery systems utilizing liquid crystal structures
|
|
HUP0100065A2
(hu)
|
1997-12-08 |
2001-08-28 |
Byk Gulden Lomberg Chemische Fabrik Gmbh. |
Savérzékeny vegyületet tartalmazó új kúp gyógyszerforma
|
|
WO1999029300A1
(en)
|
1997-12-10 |
1999-06-17 |
Rtp Pharma Inc. |
Self-emulsifying fenofibrate formulations
|
|
US6013665A
(en)
|
1997-12-16 |
2000-01-11 |
Abbott Laboratories |
Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
|
|
AU2117399A
(en)
|
1998-01-20 |
1999-08-02 |
Applied Analytical Industries, Inc. |
Oral liquid compositions
|
|
US6086376A
(en)
|
1998-01-30 |
2000-07-11 |
Rtp Pharma Inc. |
Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
|
|
FR2774591B1
(fr)
|
1998-02-12 |
2000-05-05 |
Lipha |
Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
|
|
ID25908A
(id)
|
1998-03-06 |
2000-11-09 |
Novartis Ag |
Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
|
|
DK173431B1
(da)
|
1998-03-20 |
2000-10-23 |
Gea Farmaceutisk Fabrik As |
Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
|
|
CA2268211A1
(en)
|
1998-04-13 |
1999-10-13 |
Medical College Of Hampton Roads |
Control of selective estrogen receptor modulators
|
|
WO1999059544A2
(en)
|
1998-05-18 |
1999-11-25 |
Takeda Chemical Industries, Ltd. |
Orally disintegrable tablets
|
|
DE1015046T1
(de)
|
1998-07-14 |
2001-02-08 |
Em Industries, Inc. |
Mikrodispersions-verabreichungssystem für arzneimittel
|
|
ES2157731B1
(es)
|
1998-07-21 |
2002-05-01 |
Liconsa Liberacion Controlada |
Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
|
|
US6174547B1
(en)
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
|
FR2783421B1
(fr)
|
1998-09-17 |
2000-11-24 |
Cll Pharma |
Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications
|
|
US5993880A
(en)
|
1998-10-01 |
1999-11-30 |
Kraft Foods Inc. |
Non-staining, acid-stable, cold-water-soluble, edible green color and compositions for preparing acidic foods and beverages
|
|
US6977083B1
(en)
|
1998-10-02 |
2005-12-20 |
Jenapharm Gmbh & Co. Kg |
Bioadhesive tablet containing testosterone/testosterone ester mixtures and method for producing a predetermined testosterone time-release profile with same
|
|
PE20001227A1
(es)
|
1998-10-30 |
2000-11-06 |
Hoffmann La Roche |
Procesos para producir una composicion de isotretinoina
|
|
JP2002532539A
(ja)
|
1998-12-18 |
2002-10-02 |
アボット・ラボラトリーズ |
脂質調節剤を含む新規な製剤
|
|
US6180138B1
(en)
|
1999-01-29 |
2001-01-30 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
|
US6383517B1
(en)
|
1999-01-29 |
2002-05-07 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
|
US6447806B1
(en)
|
1999-02-25 |
2002-09-10 |
Novartis Ag |
Pharmaceutical compositions comprised of stabilized peptide particles
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US7374779B2
(en)
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
US20030104048A1
(en)
|
1999-02-26 |
2003-06-05 |
Lipocine, Inc. |
Pharmaceutical dosage forms for highly hydrophilic materials
|
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
|
JP2003520767A
(ja)
|
1999-03-31 |
2003-07-08 |
アボット・ラボラトリーズ |
脂質調整剤を含む新規製剤
|
|
MXPA01009839A
(es)
|
1999-03-31 |
2002-06-21 |
Abbott Lab |
Nuevas formulaciones que comprenden agentes reguladores de lipido.
|
|
WO2000059512A1
(en)
|
1999-04-01 |
2000-10-12 |
Akzo Nobel N.V. |
Formulation comprising testosteron undecanoate and castor oil
|
|
GB9907715D0
(en)
|
1999-04-01 |
1999-05-26 |
Scherer Corp R P |
Pharmaceutical compositions
|
|
US6652880B1
(en)
|
1999-04-01 |
2003-11-25 |
R.P. Scherer Technologies, Inc. |
Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
|
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
WO2000071163A1
(en)
|
1999-05-24 |
2000-11-30 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
GB9912476D0
(en)
|
1999-05-28 |
1999-07-28 |
Novartis Ag |
Organic compounds
|
|
US6465011B2
(en)
|
1999-05-29 |
2002-10-15 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
|
US6372251B2
(en)
|
1999-06-11 |
2002-04-16 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
|
US6982281B1
(en)
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
US20030236236A1
(en)
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
|
US20030235595A1
(en)
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
|
|
US6458383B2
(en)
|
1999-08-17 |
2002-10-01 |
Lipocine, Inc. |
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
|
|
AR024462A1
(es)
|
1999-07-01 |
2002-10-02 |
Merck & Co Inc |
Tabletas farmaceuticas
|
|
DE60020382T2
(de)
|
1999-09-21 |
2006-01-26 |
Skyepharma Canada Inc., Verdun |
Oberflächenmodifizierte teilchenförmige zusammensetzungen biologisch aktiver stoffe
|
|
US6228400B1
(en)
|
1999-09-28 |
2001-05-08 |
Carlsbad Technology, Inc. |
Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
|
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
|
US20060034937A1
(en)
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US20030180352A1
(en)
|
1999-11-23 |
2003-09-25 |
Patel Mahesh V. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
EP1108425B1
(en)
|
1999-12-16 |
2005-06-08 |
Laboratorio Medinfar-Produtos Farmaceuticos, S.A. |
New stable multi-unitary pharmaceutical preparations containing substituted benzimidazoles
|
|
CZ20022047A3
(cs)
|
1999-12-23 |
2003-09-17 |
Pfizer Products Inc. |
Farmaceutické kompozice poskytující zvýšenou koncentraci léčiva
|
|
PT1239831E
(pt)
|
1999-12-23 |
2013-01-23 |
Mayne Pharma International Pty Ltd |
Composições farmacêuticas melhoradas para fármacos fracamente solúveis
|
|
US6340471B1
(en)
|
1999-12-30 |
2002-01-22 |
Alvin Kershman |
Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
|
|
FR2803203B1
(fr)
|
1999-12-31 |
2002-05-10 |
Fournier Ind & Sante |
Nouvelles formulations galeniques du fenofibrate
|
|
US20020102301A1
(en)
|
2000-01-13 |
2002-08-01 |
Joseph Schwarz |
Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
|
|
US7025979B2
(en)
|
2000-02-15 |
2006-04-11 |
Schering Ag |
Male contraceptive formulation comprising norethisterone
|
|
US6468559B1
(en)
|
2000-04-28 |
2002-10-22 |
Lipocine, Inc. |
Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methods
|
|
WO2002000261A2
(en)
|
2000-06-26 |
2002-01-03 |
Monsanto Technology Llc |
Surfactant-containing formulations for extended release of somatotropin
|
|
EP1573416A4
(en)
|
2000-07-07 |
2010-01-27 |
Fenwal Inc |
MEDICAL SYSTEM, METHOD AND DEVICE USING MEMS
|
|
DE60115464T2
(de)
|
2000-08-23 |
2006-06-14 |
Akzo Nobel Nv |
Testosteron-ester formulierung zur anwendung am menschen
|
|
US20040002482A1
(en)
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
|
JP4637338B2
(ja)
|
2000-09-22 |
2011-02-23 |
大塚製薬株式会社 |
シロスタゾール有核錠
|
|
US6887493B2
(en)
|
2000-10-25 |
2005-05-03 |
Adi Shefer |
Multi component controlled release system for oral care, food products, nutraceutical, and beverages
|
|
US6589562B1
(en)
|
2000-10-25 |
2003-07-08 |
Salvona L.L.C. |
Multicomponent biodegradable bioadhesive controlled release system for oral care products
|
|
US20020103139A1
(en)
|
2000-12-01 |
2002-08-01 |
M. Weisspapir |
Solid self-emulsifying controlled release drug delivery system composition for enhanced delivery of water insoluble phytosterols and other hydrophobic natural compounds for body weight and cholestrol level control
|
|
US20060142257A1
(en)
|
2001-01-19 |
2006-06-29 |
Eberhard Nieschlag |
Male contraceptive formulation comprising norethisterone
|
|
DE10108614B4
(de)
|
2001-02-22 |
2005-04-28 |
Aquanova Ger Solubilisate Tech |
Wasserlösliches Konzentrat eines stoffwechselbeeinflussenden Wirkstoffes
|
|
AUPR573001A0
(en)
|
2001-06-15 |
2001-07-12 |
Glaxo Wellcome Australia Ltd |
Lymphatic drug delivery system
|
|
US20030022875A1
(en)
|
2001-07-27 |
2003-01-30 |
Wilson Leland F. |
As-needed administration of orally active androgenic agents to enhance female sexual desire and responsiveness
|
|
US6665880B2
(en)
|
2001-11-01 |
2003-12-23 |
Kimberly-Clark Worldwide, Inc. |
Protective garments with glove flaps
|
|
US6630134B1
(en)
|
2002-01-08 |
2003-10-07 |
Zenitech Llc |
Guerbet wax esters in personal care applications
|
|
ES2305434T3
(es)
|
2002-02-01 |
2008-11-01 |
Pfizer Products Inc. |
Composiciones framaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas.
|
|
US20030186892A1
(en)
|
2002-03-28 |
2003-10-02 |
Rajneesh Taneja |
Enhancement of endogenous gonadotropin production
|
|
US20040002445A1
(en)
|
2002-03-28 |
2004-01-01 |
Rajneesh Taneja |
Enhancement of endogenous gonadotropin production
|
|
DE10218107A1
(de)
|
2002-04-23 |
2003-11-20 |
Jenapharm Gmbh |
Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen
|
|
US20050287203A1
(en)
|
2002-05-08 |
2005-12-29 |
Nijs De H |
Formulation comprising testosteron undecanoate and castor oil
|
|
AU2003285189B2
(en)
|
2002-11-14 |
2006-07-27 |
Shear/Kershman Laboratories, Inc. |
Oral testosterone delivery system with improved sustained release
|
|
US20040115287A1
(en)
|
2002-12-17 |
2004-06-17 |
Lipocine, Inc. |
Hydrophobic active agent compositions and methods
|
|
US20050100608A1
(en)
|
2003-02-21 |
2005-05-12 |
Watson Pharmaceuticals, Inc. |
Testosterone oral dosage formulations and associated methods
|
|
JO2505B1
(en)
|
2003-03-14 |
2009-10-05 |
باير شيرنغ فارما اكتنجيسيلشافت |
Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
|
|
US6913244B1
(en)
|
2003-05-02 |
2005-07-05 |
Gordon Edgar Atkinson |
Urinary slide valve
|
|
CA2532931A1
(en)
|
2003-08-04 |
2005-02-10 |
Pfizer Products Inc. |
Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
|
|
JP5180474B2
(ja)
|
2003-08-04 |
2013-04-10 |
カムルス エービー |
両親媒性粒子の特性を改良する方法
|
|
WO2005020913A2
(en)
|
2003-08-25 |
2005-03-10 |
Combinatorx, Incorporated |
Formulations, conjugates, and combinations of drugs for the treatment of neoplasms
|
|
JP5069001B2
(ja)
|
2003-10-10 |
2012-11-07 |
ベロクシス ファーマシューティカルズ エー／エス |
フィブラートを含む固体投与形態
|
|
US20050096365A1
(en)
|
2003-11-03 |
2005-05-05 |
David Fikstad |
Pharmaceutical compositions with synchronized solubilizer release
|
|
US20060003002A1
(en)
|
2003-11-03 |
2006-01-05 |
Lipocine, Inc. |
Pharmaceutical compositions with synchronized solubilizer release
|
|
US7138389B2
(en)
|
2004-02-09 |
2006-11-21 |
University Of Washington |
Oral androgen therapy using modulators of testosterone bioavailability
|
|
US20050220825A1
(en)
|
2004-03-10 |
2005-10-06 |
Adrian Funke |
Molecular dispersions of drospirenone
|
|
EP1761265A2
(en)
|
2004-06-28 |
2007-03-14 |
ALZA Corporation |
A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
|
|
US20060051406A1
(en)
|
2004-07-23 |
2006-03-09 |
Manjeet Parmar |
Formulation of insoluble small molecule therapeutics in lipid-based carriers
|
|
PL1778187T3
(pl)
|
2004-08-04 |
2012-09-28 |
Camurus Ab |
Kompozycje tworzące nielamelarne dyspersje
|
|
US20060106004A1
(en)
|
2004-11-12 |
2006-05-18 |
Brody Steven A |
Unique methods and formulations of bio-identical sex steroids for the treatment of pathophysiologic aberrations of menopause
|
|
US20060134210A1
(en)
|
2004-12-22 |
2006-06-22 |
Astrazeneca Ab |
Solid dosage form comprising proton pump inhibitor and suspension made thereof
|
|
RU2406480C2
(ru)
|
2005-04-08 |
2010-12-20 |
Озфарма Пти Лтд |
Трансбуккальная система доставки
|
|
CA2604431A1
(en)
|
2005-04-13 |
2006-10-26 |
Unimed Pharmaceuticals, Inc. |
Method of increasing testosterone and related steroid concentrations in women
|
|
CN101217963A
(zh)
|
2005-04-15 |
2008-07-09 |
克劳拉斯医疗有限公司 |
疏水性药物给药系统及含有疏水性药物的组合物
|
|
US8492369B2
(en)
*
|
2010-04-12 |
2013-07-23 |
Clarus Therapeutics Inc |
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
|
|
US8241664B2
(en)
|
2005-04-15 |
2012-08-14 |
Clarus Therapeutics, Inc |
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
|
|
EP1905274A1
(en)
|
2005-06-30 |
2008-04-02 |
Philips Intellectual Property & Standards GmbH |
Method and system for controlling the output of a luminaire
|
|
US7400031B2
(en)
|
2005-09-19 |
2008-07-15 |
International Business Machines Corporation |
Asymmetrically stressed CMOS FinFET
|
|
FR2895679B1
(fr)
|
2005-12-29 |
2012-06-08 |
Pf Medicament |
Stabilisation de testosterone au sein de dispositifs transdermiques
|
|
WO2007100614A2
(en)
|
2006-02-24 |
2007-09-07 |
Scidose, Llc |
STABLE NON-CRYSTALLINE FORMULATION COMPRISING HMG-CoA REDUCTASE INHIBITOR
|
|
GB0807605D0
(en)
|
2008-04-28 |
2008-06-04 |
Diurnal Ltd |
Lipid composition
|
|
US20130225544A1
(en)
|
2009-01-08 |
2013-08-29 |
Lipocine Inc. |
Lipobalanced long chain testosterone esters for oral delivery
|
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
|
EP2229936B1
(en)
|
2009-03-09 |
2015-05-06 |
PharmaSol GmbH |
Nanonized testosterone formulations for improved bioavailability
|
|
US20110160168A1
(en)
|
2009-12-31 |
2011-06-30 |
Differential Drug Development Associates, Llc |
Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
|
|
US20110263552A1
(en)
|
2009-12-31 |
2011-10-27 |
Sov Therapeutics |
Modulation of side effect profile of 5-alpha reductase inhibitor therapy
|
|
WO2011112747A1
(en)
|
2010-03-09 |
2011-09-15 |
Catholic Healthcare West |
Methods for inhibiting preterm labor and uterine contractility disorders and preventing cervical ripening
|
|
PH12012502016A1
(en)
|
2010-04-12 |
2013-01-21 |
Clarus Therapeutics Inc |
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
|
|
US20140309202A1
(en)
|
2010-11-30 |
2014-10-16 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US20120135074A1
(en)
|
2010-11-30 |
2012-05-31 |
Chandrashekar Giliyar |
High-Strength Testosterone Undecanoate Compositions
|
|
US20120148675A1
(en)
*
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
|
US20130178454A1
(en)
|
2011-11-17 |
2013-07-11 |
Shalender Bhasin |
Combination of testosterone and ornithine decarboxylase (odc) inhibitors
|
|
WO2015100406A1
(en)
|
2013-12-26 |
2015-07-02 |
Clarus Therapeutics, Inc. |
Use of oral pharmaceutical products combining testosterone esters with hypolipidemic agents
|
|
CN106999502A
(zh)
*
|
2014-08-28 |
2017-08-01 |
来普卡公司 |
药物组合物和方法
|
|
WO2016033556A1
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
|
|
RU2017111503A
(ru)
|
2014-08-29 |
2018-10-05 |
Липосин Инк. |
КОМПОЗИЦИИ(17-β)-3-ОКСОАНДРОСТ-4-ЕН-17-ИЛ УНДЕКАНОАТА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
|
|
US20160184321A1
(en)
*
|
2014-09-24 |
2016-06-30 |
Lipocine Inc. |
Compositions and their use in oral dosing regimens
|
|
US20160361322A1
(en)
|
2015-06-15 |
2016-12-15 |
Lipocine Inc. |
Composition and method for oral delivery of androgen prodrugs
|
|
US20180147215A1
(en)
*
|
2016-11-28 |
2018-05-31 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|